Fine-grained facial phenotype–genotype analysis in Wolf–Hirschhorn syndrome
暂无分享,去创建一个
Peter Hammond | Francesca Forzano | Oliver Quarrell | Femke Hannes | Susan Parekh | Michael Suttie | Sarah T South | John C Carey | S. South | K. Devriendt | J. Vermeesch | P. Hammond | M. Suttie | S. Parekh | J. Carey | F. Faravelli | O. Quarrell | D. McMullan | F. Forzano | Koen Devriendt | Joris Robert Vermeesch | Dominic McMullan | Francesca Faravelli | Steve Williams | F. Hannes | Steve Williams
[1] J. Opitz,et al. A double cryptic chromosome imbalance is an important factor to explain phenotypic variability in Wolf–Hirschhorn syndrome , 2004, European Journal of Human Genetics.
[2] Tim Hutton,et al. Reproducibility of soft tissue landmarks on three-dimensional facial scans. , 2006, European journal of orthodontics.
[3] A. Battaglia,et al. Comprehensive analysis of Wolf–Hirschhorn syndrome using array CGH indicates a high prevalence of translocations , 2008, European Journal of Human Genetics.
[4] M. Volleth,et al. Two further cases of WHS with unbalanced de novo translocation t(4;8) characterised by CGH and FISH , 2001, Journal of medical genetics.
[5] U. Wolf,et al. [Deficiency on the short arms of a chromosome No. 4]. , 1965, Humangenetik.
[6] U. Wolf,et al. Bericht über vier Trisomien 18 und ein Trisomie-18-Mosaik , 2004, Humangenetik.
[7] S. Knuutila,et al. MSX1 Gene is Deleted in Wolf-Hirschhorn Syndrome Patients with Oligodontia , 2003, Journal of dental research.
[8] P Hammond,et al. Face–brain asymmetry in autism spectrum disorders , 2008, Molecular Psychiatry.
[9] A. Karmiloff-Smith,et al. Discriminating power of localized three-dimensional facial morphology. , 2005, American journal of human genetics.
[10] T. Hutton. Dense surface models of the human face , 2004 .
[11] Peter Hammond,et al. GTF2IRD1 in Craniofacial Development of Humans and Mice , 2005, Science.
[12] U. Surti,et al. Pitt-Rogers-Danks syndrome: the result of a 4p microdeletion. , 1996, American journal of medical genetics.
[13] Peter Hammond,et al. The use of 3D face shape modelling in dysmorphology , 2007, Archives of Disease in Childhood.
[14] A. Rigby,et al. An epidemiological study of Wolf-Hirschhorn syndrome: life expectancy and cause of mortality , 2001, Journal of medical genetics.
[15] K. Hirschhorn,et al. Deletion of short arms of chromosome 4–5 in a child with defects of midline fusion , 2004, Humangenetik.
[16] J. Lupski,et al. Inhibition of neural crest migration underlies craniofacial dysmorphology and Hirschsprung's disease in Bardet–Biedl syndrome , 2008, Proceedings of the National Academy of Sciences.
[17] Peter Hammond,et al. Estimating average growth trajectories in shape-space using kernel smoothing , 2003, IEEE Transactions on Medical Imaging.
[18] K. Hirschhorn,et al. The etiology of Wolf-Hirschhorn syndrome. , 2005, Trends in genetics : TIG.
[19] J. Waddington,et al. Facial surface analysis by 3D laser scanning and geometric morphometrics in relation to sexual dimorphism in cerebral–craniofacial morphogenesis and cognitive function , 2005, Journal of anatomy.
[20] K. Devriendt,et al. Genotype–phenotype correlation in 21 patients with Wolf–Hirschhorn syndrome using high resolution array comparative genome hybridisation (CGH) , 2007, Journal of Medical Genetics.
[21] R. Hennekam,et al. Genotype-phenotype correlations of 39 patients with Cornelia De Lange syndrome: the Dutch experience , 2005, Journal of Medical Genetics.
[22] P. Marynen,et al. Mild Wolf-Hirschhorn syndrome: micro-array CGH analysis of atypical 4p16.3 deletions enables refinement of the genotype-phenotype map , 2004, Journal of Medical Genetics.
[23] P. Hammond,et al. Three-dimensional face shape in Fabry disease , 2007, European Journal of Human Genetics.
[24] H. Dörr,et al. First known microdeletion within the Wolf-Hirschhorn syndrome critical region refines genotype-phenotype correlation. , 2001, American journal of medical genetics.
[25] D. Horn,et al. Effect of the size of the deletion and clinical manifestation in Wolf-Hirschhorn syndrome: analysis of 13 patients with a de novo deletion , 2000, European Journal of Human Genetics.
[26] R. Hochstenbach,et al. Wolf–Hirschhorn syndrome facial dysmorphic features in a patient with a terminal 4p16.3 deletion telomeric to the WHSCR and WHSCR 2 regions , 2009, European Journal of Human Genetics.
[27] F. Faravelli,et al. Mother to son amplification of a small subtelomeric deletion: A new mechanism of familial recurrence in microdeletion syndromes , 2007, American journal of medical genetics. Part A.
[28] Kristina Aldridge,et al. Precision and error of three‐dimensional phenotypic measures acquired from 3dMD photogrammetric images , 2005, American journal of medical genetics. Part A.
[29] A. Battaglia,et al. Wolf-Hirschhorn (4p-) syndrome. , 2005, Advances in pediatrics.
[30] Karl L. Wuensch,et al. Misanthropy, idealism and attitudes towards animals , 2002 .
[31] A. Battaglia,et al. Genotype-phenotype correlations and clinical diagnostic criteria in Wolf-Hirschhorn syndrome. , 2000, American journal of medical genetics.
[32] H. Brunner,et al. Cytogenetic abnormalities in two new patients with Pitt-Rogers-Danks phenotype. , 1996, American journal of medical genetics.
[33] F. Bro-Rasmussen,et al. [Multiple congenital malformations]. , 1961, Nordisk medicin.
[34] G. Lazjuk,et al. Wolf-Hirschhorn syndrome. , 1971, American journal of diseases of children.
[35] Dagmar Wieczorek,et al. Heterozygous submicroscopic inversions involving olfactory receptor-gene clusters mediate the recurrent t(4;8)(p16;p23) translocation. , 2002, American journal of human genetics.
[36] D. Wieczorek,et al. Unexpected high frequency of de novo unbalanced translocations in patients with Wolf-Hirschhorn syndrome (WHS) , 2000, Journal of medical genetics.
[37] S. South,et al. Two unique patients with novel microdeletions in 4p16.3 that exclude the WHS critical regions: Implications for critical region designation , 2007, American journal of medical genetics. Part A.
[38] B. Trueb,et al. Expression of FGFRL 1 , a novel fibroblast growth factor receptor , during embryonic development , 2006 .
[39] B. Trueb,et al. Expression of FGFRL1, a novel fibroblast growth factor receptor, during embryonic development. , 2006, International journal of molecular medicine.
[40] G. Neri,et al. Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2. , 2003, American journal of human genetics.